Yueming Li aims to develop new agents that inhibit particular intramembrane proteases associated with cancer.

An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.

Biochemist Yueming Li commented on new technology that is three million times more sensitive at detecting Alzheimer's disease and certain cancers....